Multipotent mesenchymal stromal cells and immune tolerance

被引:110
作者
Noel, Daniele
Djouad, Farida
Bouffi, Carine
Mrugala, Dominique
Jorgensen, Christian
机构
[1] INSERM, U844, Montpellier, France
[2] Univ Montpellier I, UFR Med, Montpellier, France
[3] Hop St Eloi, Unite Therapie Cellulaire & Genique, Montpellier, France
[4] NIH, Cartilage Biol & Orthopaed Branch, Bethesda, MD USA
[5] Hop Lapeyronie, Serv Immunol Rhumatol, Montpellier, France
关键词
mesenchymal stem cell; immunosuppression; characterization;
D O I
10.1080/10428190701361869
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multipotent mesenchymal stromal cells or mesenchymal stem cells ( MSC) are isolated mainly from bone marrow and adipose tissue but are identified in other tissues such as synovium, periosteum or placenta. They are characterised by their property to adhere to plastic, their phenotype and their ability to differentiate into three lineages ( chondrocytes, osteoblasts and adipocytes). More recently, these cells were shown to escape immune recognition and inhibit immune responses. MSC may modulate the function of the major immune cell populations, including antigen-presenting cells, T cells, B cells and natural killer cells. The aim of this review is to focus on the molecular mechanisms, still poorly understood, which are responsible of the immunosuppressive effects mediated by the MSC. Finally, the data obtained from in vivo experimentation in various animal models as well as potential therapeutic applications will be presented.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 55 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]  
ALBINA JE, 1991, J IMMUNOL, V147, P144
[3]  
Angoulvant D, 2004, BIORHEOLOGY, V41, P469
[4]   Mesenchymal stem cells: clinical applications and biological characterization [J].
Barry, FP ;
Murphy, JM .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) :568-584
[5]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[6]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[7]  
Bhatia Rinky, 2005, Congest Heart Fail, V11, P87, DOI 10.1111/j.1527-5299.2005.03618.x
[8]   Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-γ [J].
Chan, Jennifer L. ;
Tang, Katherine C. ;
Patel, Anoop P. ;
Bonilla, Larissa M. ;
Pierobon, Nicola ;
Ponzio, Nicholas M. ;
Rameshwar, Pranela .
BLOOD, 2006, 107 (12) :4817-4824
[9]   Human mesenchymal stem cells modulate B-cell functions [J].
Corcione, A ;
Benvenuto, F ;
Ferretti, E ;
Giunti, D ;
Cappiello, V ;
Cazzanti, F ;
Risso, M ;
Gualandi, F ;
Mancardi, GL ;
Pistoia, V ;
Uccelli, A .
BLOOD, 2006, 107 (01) :367-372
[10]   Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential [J].
D'Ippolito, G ;
Diabira, S ;
Howard, GA ;
Menei, P ;
Roos, BA ;
Schiller, PC .
JOURNAL OF CELL SCIENCE, 2004, 117 (14) :2971-2981